Condition: Serous cystadenocarcinoma ovary
rs1023835002
in
B2M;PATL2
gene and
Serous cystadenocarcinoma ovary
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs121913370
in
BRAF
gene and
Serous cystadenocarcinoma ovary
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519816
in
ERBB2
gene and
Serous cystadenocarcinoma ovary
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519895
in
FBXW7
gene and
Serous cystadenocarcinoma ovary
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs104894230
in
HRAS;LRRC56
gene and
Serous cystadenocarcinoma ovary
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs104894229
in
LRRC56;HRAS
gene and
Serous cystadenocarcinoma ovary
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs11554290
in
NRAS
gene and
Serous cystadenocarcinoma ovary
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519879
in
PATL2;B2M
gene and
Serous cystadenocarcinoma ovary
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs104886003
in
PIK3CA
gene and
Serous cystadenocarcinoma ovary
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519946
in
PPP2R1A
gene and
Serous cystadenocarcinoma ovary
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519747
in
TP53
gene and
Serous cystadenocarcinoma ovary
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.